As I look back on the past year, it is clear that 2025 was one of the most significant and value-creating years in Halozyme Therapeutics, Inc.'s history. This level of execution has created a clear ...

Sean T. Saint: and I want to take a brief moment to reflect on it before we dive into the details of our Q4 and full year 2025 performance. Beta Bionics, Inc. exists to deliver solutions to people ...

A Jamaican franchise will return to the Caribbean Premier League (CPL) this year under the new ownership of Kingsmen Sports ...

Optune Pax® with the chemotherapy combination of gemcitabine and nab-paclitaxel is the first treatment to be FDA approved in ...